FDA Says Digital Tech Use In Trials Should Measure Outcomes Meaningful To Patients

The FDA advises clinical trial sponsors using digital health technologies such as wearables to ensure that the data collected measures outcomes meaningful to patients, emphasizing validation and relevance of health outcomes.

This Wire brief sits within Fusion42's coverage of Digital Health.